Tue.Aug 13, 2024

article thumbnail

COVID-19’s Impact on the Leading Causes of Death in the US

Drug Topics

Experts analyzed data from the National Center for Health Statistics on the leading causes of death in the US from the last 5 years.

201
201
article thumbnail

STAT+: Meet the billionaire media mogul who’s taking on the food industry

STAT

WASHINGTON — The idea for Todd Wagner’s new advocacy organization FoodFight USA, he says, came to him after visiting George Clooney in Lake Como. He’s recruited Morgan Freeman, who is “obviously” a friend. He personally lobbied Arnold Schwarzenegger and current California Gov. Gavin Newsom to support food makers’ nightmare scenario — a first-in-the-nation law banning certain food additives in the state, which was signed into law last year.

FDA 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

First FDA-Approved Digital Therapeutic to Treat Depression Now Available in App Stores

Drug Topics

Rejoyn, developed by Otsuka Pharmaceutical and Click Therapeutics, is only accessible with a prescription from a health care provider.

FDA 193
article thumbnail

STAT+: Grail announces layoffs as it looks to push forward blood-based cancer detection test

STAT

Cancer detection firm Grail announced sizable workforce cuts on Tuesday in a bid to save cash and concentrate resources on developing a blood-based test to spot early signs of dozens of cancers. The cuts will affect 30% of the biotech’s current and planned hires. Grail spokesperson Kristen Davis told STAT in an email that around 350 existing positions and 150 open roles have been eliminated.

142
142
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

FDA Approves First Monoclonal Antibody to Treat Prurigo Nodularis

Drug Topics

Two phase 3 trials evaluating nemolizumab found that 41% of patients treated with the therapy achieved at least a 4-point reduction in itch intensity at week 16.

FDA 112
article thumbnail

STAT+: Why U.S. health care cybersecurity laws are better at protecting a corpse’s privacy than patients’ lives

STAT

Two days into a cyberattack on his hospital system, Nate Couture reached the end of his cyber incident plan. “We make these incident response plans and we feel great about them,” Couture, the University of Vermont Health Network chief information security officer, told other heath care cyber professionals at a recent conference. “At the end of them, they have a box that usually says something like, ‘And then IT recovers the systems.

More Trending

article thumbnail

STAT+: Illumina lays out plan to boost growth by helping scientists interpret sequencing data

STAT

SAN DIEGO — The unwinding of Illumina’s ill-fated acquisition of Grail earlier this year left investors and the genomics community with a pressing question: What kind of company is Illumina going to be going forward? CEO Jacob Thaysen on Tuesday made clear that the sequencing firm, which controls about 80% of the current DNA-sequencer market, is essentially returning to its traditional role of creating instruments for researchers in academia, the biopharma industry, and health care

135
135
article thumbnail

Steward Health Care agrees to sell physician group to private equity affiliate in $245M deal

Fierce Healthcare

Steward Health Care has agreed to sell its physicians network, Stewardship Health, to Rural Healthcare Group, which is owned by a private equity group. | Steward Health Care has agreed to sell its doctors network, Stewardship Health, to Rural Healthcare Group, which is owned by a private equity group.

128
128
article thumbnail

Atai advances oral psychedelic in depression

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, the FDA’s recent rejection of an MDMA therapy hasn’t seemed to deter some other companies from moving ahead with psychedelics studies. We discuss that, and also some big policy developments that are coming this week.

FDA 135
article thumbnail

People need to know how to use AI now

pharmaphorum

With the implementation of advancing technologies in industry comes the parallel need for suitable upskilling of the workforce – but this doesn’t as yet always pan out, and in today’s pharmaphorum podcast COO of Enthought Mike Connell discusses the growing skills gap in R&D in life sciences and the 80/20 rule with web editor Nicole Raleigh, as well as the need for correct education of people and machines, both.

117
117
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Opinion: Aspirin after a broken bone: health equity in a $5 bottle

STAT

There are few things more exciting for researchers than to mount and complete a clinical trial that could change the practice of medicine and save lives. That’s what we experienced when The New England Journal of Medicine published our findings in January 2023 that aspirin was as effective at preventing life-threatening blood clots after surgery as was a far more expensive and more painful injectable blood thinner.

Hospitals 125
article thumbnail

Industry Voices—Empowering community health workers to improve value-based care

Fierce Healthcare

In places like rural El Paso, Texas, community health workers (CHWs) help thousands of underserved individuals obtain the food, housing and medical services they need to survive. | While there’s no silver bullet to save VBC, community-based health workers are best positioned to protect it.

120
120
article thumbnail

STAT+: Acelyrin announces layoffs, strategy shift after late-stage trial results for anti-inflammatory drug

STAT

Acelyrin, a California biotech focused on immunology and inflammatory disease, announced Tuesday that its experimental drug for a common skin disorder succeeded in a late-stage clinical trial. That’s the kind of news that’s usually accompanied by plans to apply for regulatory approval to market a new therapy. But the results didn’t show a clear edge over competing products on the market or in development.

130
130
article thumbnail

Advancing precision medicine: How real-world evidence platforms translate data into action

pharmaphorum

Learn how real-world evidence platforms use real-world data (RWD) to advance precision medicine, bridging the gap between clinical trials and real-world patient outcomes.

113
113
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

STAT+: Otsuka prices depression digital therapeutic to make it widely accessible, says it’ll lose money

STAT

Otsuka Pharmaceutical has started selling Rejoyn, its Food and Drug Administration cleared prescription app that treats the symptoms of major depressive disorder. And it’s hitting the market at a low price that Otsuka hopes will entice many people to give it a try. Otsuka will make the 6-week treatment available to patients through a prescription from their existing provider or through the treatment’s website where they can connect with a clinician from Wheel Health who can prescri

Insurance 124
article thumbnail

Remembering Paul Bannister, dear friend and finance manager

pharmaphorum

Our longtime Finance Director Paul Bannister was a part of the fabric of pharmaphorum almost from the beginning and an integral part of keeping the publication running. And, most importantly, he was the soul of the place and a friend to all.

109
109
article thumbnail

The politics of mifepristone in the 2024 election

STAT

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Hello and happy Tuesday, D.C. Diagnosis readers! I’m sad that the Olympics are already over, and it seems like the athletes receiving free health care must be too.

FDA 121
article thumbnail

Vivid Health brings generative AI into home healthcare, hospital-at-home services

Fierce Healthcare

Vivid Health is launching into the at-home care market to help clinical staff more efficiently fill out required, but time-consuming, assessment forms, reduce staff burnout and increase c | Digital health startup Vivid Health is a multispecialty care management platform that leverages generative AI to create patient care plans. The solution is particularly well suited for the home health sector, which struggles with capacity and burnout.

Hospitals 133
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Lexicon to lay off 50% of field force as it prioritizes heart failure drug, potential US diabetes launch

Fierce Pharma

Despite winning an FDA approval in 2023 and gaining clarity in May on the regulatory path forward for its Type 1 diabetes prospect sotagliflozin, Lexicon Pharmaceuticals hasn’t had an easy go of it | As part of a restructuring initiative, Lexicon Pharmaceuticals will lay off more than 75 staffers, or approximately 50% of its current field force, by the end of September.

FDA 102
article thumbnail

54% of Medicare eligibles enrolled in MA for 2024: KFF

Fierce Healthcare

Fifty-four percent of Medicare beneficiaries are enrolled in a private Medicare Advantage plan, and in seven states that figure tops 60%, according to a new report from KFF. | Fifty-four percent of Medicare beneficiaries are enrolled in a private Medicare Advantage plan, and in seven states that figure tops 60%, according to a new report from KFF.

130
130
article thumbnail

4 foods to avoid while on Saxenda

The Checkup by Singlecare

Read any articles on the latest strategies for losing weight or ask any friends who have been trying to shed a few pounds, and you’ll likely notice a trend: The class of weight-management drugs known as glucagon-like peptide-1 (GLP-1) agonists are having a moment. Among these is the brand-name drug Saxenda (liraglutide). This prescription medication is FDA approved to regulate appetite and promote weight loss in adults with a body mass index (BMI) of 30 or higher and those with a BMI over 27 who

article thumbnail

China CDE clears Phase 3 Study of Lisafltoclax in Newlly Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome

Pharmafile

The China Centre for Drug Evaluation (CDE) has cleared the registrational phase 3 study of lisaftoclax in combination with azacitadine for the first time in newly diagnosed patients with higher-risk myelodysplastic syndrome (MDS). The post China CDE clears Phase 3 Study of Lisafltoclax in Newlly Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome appeared first on Pharmafile.

98
article thumbnail

What Do You Do When You Hit a Weight Loss Plateau?

Compounding Pharmacy of America

Stuck in a weight loss plateau? Learn effective tips, strategies and supplements to help break through and continue your fitness journey. The post What Do You Do When You Hit a Weight Loss Plateau? appeared first on The Compounding Pharmacy of America.

article thumbnail

Does Ozempic cause headaches?

The Checkup by Singlecare

For people with Type 2 diabetes, the injectable drug Ozempic (semaglutide) can lower blood sugar, reduce the risk of heart disease, and help with weight loss. It’s a glucagon-like peptide 1 (GLP-1) receptor agonist that works several different ways to manage Type 2 diabetes. Although Ozempic doesn’t have any direct effect on the neurological system, some people have reported headaches while taking the drug.

98
article thumbnail

How personal loss and hope drove Elaine Maynard’s work in clinical trials and patient-centric technologies

Outsourcing Pharma

Driven by personal loss and inspired by the progress in disease management, Elaine has dedicated more than 20 years to the clinical trial technology industry.

105
105
article thumbnail

Dengue Vaccine TAK-003 Confirmed to be Safe, Effective

Drug Topics

TAK-003 could be a powerful combatant against the increasing global threat of dengue virus.

Vaccines 112
article thumbnail

CORRECTED: After icodec rejection, Novo Nordisk won’t file application for once-weekly insulin and semaglutide combo in US

Fierce Pharma

CORRECTED: After icodec rejection, Novo Nordisk won’t file application for once-weekly insulin and semaglutide combo in US fkansteiner Tue, 08/13/2024 - 13:42

101
101
article thumbnail

Revolutionizing partner evaluations in pharma outsourcing: expert insights

Outsourcing Pharma

In the rapidly evolving pharmaceutical industry, the process of evaluating outsourcing partners is critical to ensuring quality, efficiency, and innovation.

104
104
article thumbnail

Novartis loses bid to thwart launch of MSN's Entresto generic—for now

Fierce Pharma

After seeking to block the launch of MSN Pharmaceuticals’ recently approved Entresto generic, Novartis has hit a snag in its multiyear crusade to thwart copycats of its top-selling heart failure dr | After seeking to block the launch of MSN Pharmaceuticals’ recently approved Entresto generic, Novartis has hit a snag in its multiyear crusade to thwart copycats of its top-selling heart failure drug.

95
article thumbnail

Morning Rounds: The billionaire who wants you angry about the food supply

STAT

Want to stay on top of health news?  Sign up  to get our Morning Rounds newsletter in your inbox. We’ve got some nice awards news this morning. Yesterday, my colleague and friend Jason Mast won the the 2024 Evert Clark/Seth Payne Award , for his reporting at the intersection of medical science, business, and human lives. I asked Jason if there was a STAT story he was most proud of and he shared this heart-wrenching one from last summer when the first gene therapy was approved fo

Hospitals 103
article thumbnail

Investor activism resurfaces at Aurinia after CEO’s board role, exec pay lost majority support

Fierce Pharma

A deal to bring back former CEO Robert Foster, Ph.D., didn’t completely quell investors’ concerns about Aurinia Pharmaceuticals. | A deal to bring back former CEO Robert Foster, Ph.D., didn’t completely quell investors’ concerns about Aurinia Pharmaceuticals.

94
article thumbnail

#WeCount: In Q1 2024, women in the US received more abortions than ever, bolstered by telehealth

Fierce Healthcare

More people are receiving abortion care per month in the first quarter of 2024 than before the Supreme Court struck down the national right to abortion in the 2022 Dobbs v. | #WeCount is a national abortion reporting effort that began in April 2022, just before the Supreme Court struck down the national right to abortion. Even though 14 states have near-total abortion bans, the number of abortions rose year-over-year from 2023—and hit an all-time high.

104
104
article thumbnail

FDA approval of needle-free spray, a major breakthrough in anaphylaxis treatment

Outsourcing Pharma

Patients suffering from severe allergic reactions now have access to a new, needle-free treatment option, as the US Food and Drug Administration (FDA) has approved neffy, a 2 mg epinephrine nasal spray developed by ARS Pharmaceuticals, Inc.

FDA 94